Current Issue
Volume: 37
Number: 4
Index: December 2009
Clinical Focus: THE INJURED ATHLETE
Editorial Calendar
April 2010
Clinical Focus: Hypertension
  • Hypertension in athletes
    • Antihypertension medication and its effects on athletes
  • Risk of CVD in professional athletes
  • NSAIDs in sports medicine
  • Arterial and venous injuries in athletes
  • Family history and exercise-induced cardiac remodeling (eg, left ventricular hypertrophy)
  • Physical activity for non-athletes with hypertension
    • Exercise programs for patients with hypertension
  • Sleep changes related to hypertension
  • Resuming exercise after rhabdomyolysis
  • Gender differences in hypertension and treatment options
  • Dietary approaches to prevention and treatment hypertension
  • Exercise and the vascular wall
  • Effects of exercise on aging
  • Association between exercise and atherosclerosis
  • Sodium ingestion and hypertension
  • Arrhythmia and "holiday heart"
  • Increased arterial stiffness in children, patients with type 2 diabetes
  • COPD
View More
Submission deadline: March 05
Fast-Track deadline: March 15
Fast-Track
About
Fast-Track peer review is available for those papers requiring immediate review (for an additional fee). Complete peer review is finalized in 1-2 weeks and comments are provided to the author within 72 hours of their receipt by the editorial office. Authors are asked to submit a revised manuscript within 10-12 days. Accepted manuscripts are processed within 2-3 weeks, published online within 3 business days of final author approval, and in print in the next available issue.
Submissions
Submit your FAST-TRACK manuscript online today. It's fast, it's easy! Just follow the detailed instructions, fill in all the required fields, and upload your manuscript.
Get started NOW!
Contacts
Libraries:
[email protected]

Reprints:
[email protected]

Subscriptions:
[email protected]

Supplements:
[email protected]

Document Delivery Services
1986-2010:

[email protected]

Editorial:
[email protected] [email protected]

Website:
[email protected]

Managing Director:
John Elduff
Phone: 610-889-3733
Fax: 1-866-297-3168
[email protected]

General Information
Phone: 610-889-3733
Fax: 1-866-297-3168
1235 Westlakes Drive
Suite 320
Berwyn, PA 19312
doi: 10.3810/psm.2008.12.7
The Physician and Sportsmedicine: Volume 36: No.1
Effect of Fish Oil-Derived Omega-3 Polyunsaturated Fatty Acid Supplementation on Exercise-Induced Bronchoconstriction and Immune Function in Athletes
Timothy D. Mickleborough, PhD; Martin R. Lindley, PhD; and Gregory S. Montgomery, MD
Abstract: Exercise-induced bronchoconstriction (EIB) is a condition in which vigorous physical activity triggers acute airway obstruction in asthmatic and nonasthmatic individuals with hyperresponsive airways. Studies have shown that inflammatory mediators and contraction of airway smooth muscle are central components in the pathogenesis of EIB, and it has long been recognized that leukotrienes and prostaglandins play an important role in the EIB response. Clinical responses to current therapy, such as leukotriene modifiers and corticosteroids are heterogeneous, and even with optimal treatment there is a substantial burden of unaddressed disease. While daily medications such as leukotriene modifiers provide only modest protection against symptoms, prolonged use of several medications can result in reduced effectiveness or tachyphylaxis. Although the treatment of EIB almost exclusively involves pharmacotherapy, there is now convincing evidence that dietary modification has the potential to reduce the severity of this condition. Omega-3 polyunsaturated fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in fish oils, compete with arachidonic acid as substrates for the formation of proinflammatory mediators, such as leukotrienes, prostaglandins, and cytokines. Studies have shown that 3 weeks of fish oil supplementation, rich in EPA and DHA, reduces exercise-induced airway narrowing, airway inflammation, and bronchodilator use in elite athletes and asthmatic individuals with EIB. Based on the evidence to date, fish oil supplementation may represent a potentially beneficial treatment intervention for athletes and asthmatic individuals with EIB. From this, it follows that physicians should pay more attention to what their asthma/EIB patients eat, and incorporate dietary assessment and nutritional counseling in their everyday practice.

Keywords: omega-3; polyunsaturated fatty acid; fish oil; exercise-induced bronchoconstriction
(read)